Zoledronate prevented fractures in four large trials in cohorts that varied from low to high risk of fracture. Cost-effectiveness analyses are important tools used in funding and regulatory decisions about pharmaceutical agents, and zoledronate generally has a... ...

请注册登录后继续浏览